Art. 28 para. 5 HCR is no longer applicable due to an unlawful act of suspension by the European Commission The former president judge at the German Constitutional Court Professor Dr. Udo Di Fabio stated in a legal opinion that the suspension in the assessment… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of three (3) new members at its quarterly Members Meeting on October 19th 2022 following Board approval. The new members joining EUCOPE network are: Genesis Pharma, Mirati Therapeutics and Moderna. During the announcement, EUCOPE’s Secretary… read more
Remap Consulting has launched a short survey to gather feedback from biotech, pharmaceutical and medical device companies on the new EU HTA regulation, and how prepared they are for it. Remap is eager to get feedback from small and mid-sized companies as part of the… read more
On the 25th and 26th of October 2022, experts on rare diseases joined the Expert Conference on Rare Diseases in Prague organised by the Czech Presidency of the EU together with EURORDIS. The event built on a series of technical and ministerial gatherings on proposals… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Cesar Rubio, Associate Director, Government and Public Affairs, Grifols. César Rubio is Associate Director,… read more
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have concerns on the current direction of the implementation of the EU HTA Regulation. We are firmly convinced that the input from patient organizations, healthcare professionals, industry and HTA experts and… read more
EUCOPE discusses solutions across the R&D lifecycle to build a European system fit for transformative therapies On the 13th of October 2022, the European Alliance for Transformative Therapies (TRANSFORM) came together with the MEP Interest Group to launch an MEP Charter in the European Parliament…. read more
On 13 October 2022, Alexion held a high-level conference, as part of the “Rare Conversations” event series, on rare disease policies at the Bibliotheque Solvay in Brussels. Alexion’s recent conference in Brussels, Rare Disease Policies 2022, was an insightful look into the possibilities for the… read more
Sounds of Science Podcast – Episode 9 Advanced Therapy Medicinal Products (ATMPs): How they will be impacted by the General Pharmaceutical Legislation On our latest episode, we explore the topic of Advanced Therapy Medical Products, or ATMPs. This covers a wide range of therapies, but… read more
We are looking to recruit an experienced Sr. Manager/Director of Government Affairs & Public Policy to lead, design and develop positions as well as advocacy strategies for EUCOPE’s engagement with EU and international institutions and other stakeholders on key issues such as general pharmaceutical legislation,… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View